رجوع
نطاق اليوم
KWD 34.39
KWD 34.39
نطاق 52 أسبوعًا
KWD 6.98
KWD 34.39
حجم التداول
21,644
متوسط 50 يوم / 200 يوم
KWD 13.01
/
KWD 8.48
الإغلاق السابق
KWD 34.39
Quick Summary
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (631 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -67.0 | 0.2 |
| P/B | — | 3.0 |
| ROE % | — | 3.6 |
| Net Margin % | -72.2 | 3.8 |
| Rev Growth 5Y % | 32.9 | 10.0 |
| D/E | — | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.99
KWD 1.33 – KWD 2.45
|
145.93M | 1 |
| FY2029 |
KWD 3.10
KWD 2.08 – KWD 3.82
|
152.21M | 1 |
| FY2028 |
KWD 1.42
KWD 0.95 – KWD 1.74
|
93.69M | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-09 | -KWD 0.31 | -KWD 0.57 | -85.7% |
| 2025-06-17 | -KWD 0.45 | -KWD 0.13 | +70.7% |
| 2024-12-03 | N/A | -KWD 0.55 | — |
| 2024-06-25 | N/A | -KWD 0.63 | — |
| 2023-12-21 | N/A | -KWD 0.31 | — |
| 2023-03-31 | N/A | -KWD 0.79 | — |
| 2022-09-30 | N/A | -KWD 0.53 | — |
| 2022-03-31 | N/A | -KWD 0.58 | — |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
النقاط الرئيسية
Revenue grew 32.91% annually over 5 years — strong growth
Generating 17.81M in free cash flow
PEG of 0.36 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 145.92%
Capital efficient — spends only 6.50% of revenue on capex
النمو
Revenue Growth (5Y)
32.91%
Revenue (1Y)178.83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
N/A
ROIC-19.18%
Net Margin-72.19%
Op. Margin-42.44%
الأمان
Debt / Equity
N/A
Current Ratio2.70
Interest Coverage-2.13
التقييم
P/E Ratio
-66.97
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 178.83% | Revenue Growth (3Y) | 60.26% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 32.91% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 25.54M | Net Income (TTM) | -18.44M |
| ROE | N/A | ROA | -20.38% |
| Gross Margin | 100.00% | Operating Margin | -42.44% |
| Net Margin | -72.19% | Free Cash Flow (TTM) | 17.81M |
| ROIC | -19.18% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.70 |
| Interest Coverage | -2.13 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -66.97 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 48.34 |
| PEG Ratio | 0.36 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 38.39 | Fwd Earnings Yield | N/A |
| FCF Yield | 1.44% | ||
| Market Cap | 1.23B | Enterprise Value | 1.23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25.54M | 9.16M | 9.94M | 4.09M | 8.19M |
| Net Income | -18.44M | -25.04M | -32.01M | -24.81M | -19.02M |
| EPS (Diluted) | -0.63 | -0.88 | -1.27 | -1.00 | -0.86 |
| Gross Profit | 25.54M | 9.16M | 9.94M | 4.09M | 6.74M |
| Operating Income | -10.84M | -20.98M | -24.03M | -23.81M | -15.61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90.45M | 36.95M | 29.34M | 44.30M | 63.61M |
| Total Liabilities | 106.82M | 77.77M | 71.63M | 57.67M | 54.69M |
| Shareholders' Equity | -16.37M | -40.82M | -42.29M | -13.37M | 8.92M |
| Total Debt | 58.76M | 58.96M | 57.71M | 47.49M | 43.35M |
| Cash & Equivalents | 59.04M | 19.46M | 6.47M | 24.62M | 47.10M |
| Current Assets | 80.62M | 27.26M | 19.57M | 34.07M | 56.33M |
| Current Liabilities | 29.87M | 16.47M | 57.03M | 38.24M | 13.60M |